期刊文献+

^(18)F-FDG分子符合成像非肿瘤性摄取与对策 被引量:5

Nonmalignant accumulations and its decision of ^(18)F-FDG molecular coincidence imaging
暂未订购
导出
摘要 18F-FDG显像可以提供肿瘤细胞生物特性信息,且大多数肿瘤具有靶/非靶高比率的特性,目前已有效地应用于全身各种肿瘤。但是,除肿瘤外,正常组织及一些良性病变也可摄取18F-FDG,这些非肿瘤摄取常可造成假阳性或者掩盖恶性肿瘤灶。通过阐述各种非肿瘤性摄取,包括生理性、良性、炎症性摄取的特点以及鉴别点,图像融合、双时相显像应用到非肿瘤性摄取的鉴别,认为同机图像融合是鉴别肿瘤性摄取与生理性摄取首选方法。 F-FDG imaging can provide information about the biologic characteristics o f malignant cells,and has high target-to-nontarget ratios in most common n eoplasms,recently has been successfully used in various neoplasms throughout the body.However 18 F-FDG is a non specific tracer,and it has been found to accumulate at site s of normal tissue and some benign pathologic.This uptake of nonmalignant tiss ue may be misinterpreted as a false positive result or mask a nearby malignant lesion.We describe various nonmalignant uptake's characteristic and differenti al including physiologic,benign,infection and inflammation,image fusion,dual time point imaging be applied to distinguish nonmalignant accumulations.Con sider the combined imaging fusion is the first optimal modality in distinguish m alignant accumulations from physiologic.
作者 李林法
出处 《国外医学(放射医学核医学分册)》 2002年第5期205-209,共5页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 ^18F-氟代脱氧葡萄糖 生理性摄取 肿瘤 鉴别诊断 F-fluoro-2-deoxy-D-glucose physiological accumulations benign pathol ogic neoplasms differential
  • 相关文献

参考文献28

  • 1Shreve PD, Anzai Y, Wahl RL. Pitfall in oncologic diagnosis with FDG PET imaging: physiologic and benign variants [J].Radiographics, 1999, 19(1): 61-77.
  • 2Brigid GA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations[J]. Am J Roentgenol, 1997,169: 1675-1680.
  • 3Miraldi F, Vesselle H, Faulhaber PF, et al. Elimination of artifactual accumulation of FDO in PET imaging of colorectal cancer[J]. Clin Nucl Med, 1998, 23:3-7.
  • 4Conti PS, Durshi JM, Singer PA, et ah Incidence of thyroid gland uptake of F-18 FDG in cancer patients[J]. Radiology,1997, 205: 220.
  • 5Bar-Shalom R. Muscle uptake of 18-fluorine fluoro deoxyglucose[J[. Semin Nucl Med, 2000, 30 (4): 306-309.
  • 6Engel H, Steinert H, Buck A, et al. Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations [J]. J Nucl Med, 1996, 37: 441-446.
  • 7Mossberg KA, Mommession JI, Taegtmeyer H. Skeletal muscle glucose uptake during short-term contractile activity in vivo:effect of prior contractions [J]. Metabolism, 1993, 42:1609-1616.
  • 8Kostakoglu L, Wong JCH, Barrington SF, et al. Speech-related visualization of laryngeal muscles with fluorine-18-FDG[J]. J Nucl Med, 1996, 37: 1771-1773.
  • 9Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine 18-FDG: effect on oral diazepam[J]. J Nucl Med, 1996, 37: 1127-1129.
  • 10赵军,林祥通.^(18)F-FDG PET诊断肿瘤应考虑的几个问题[J].国外医学(放射医学核医学分册),1999,23(6):241-245. 被引量:8

二级参考文献1

  • 1Paul D. Shreve. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease[J] 1998,European Journal of Nuclear Medicine(3):259~264

共引文献7

同被引文献55

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部